Published in J Clin Pathol on September 01, 1979
Simultaneous quantification of Epstein-Barr virus, cytomegalovirus, and human herpesvirus 6 DNA in samples from transplant recipients by multiplex real-time PCR assay. J Clin Microbiol (2007) 1.08
Quantitative measurement of varicella-zoster virus infection by semiautomated flow cytometry. Appl Environ Microbiol (2009) 0.83
Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dye. Virol J (2010) 0.81
Virus infections in renal transplant recipients. Ulster Med J (1981) 0.75
Genital herpes. Br Med J (1980) 0.75
VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. Lancet (1964) 14.21
THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS. Proc R Soc Med (1965) 10.85
Para-infectious encephalomyelitis and related syndromes; a critical review of the neurological complications of certain specific fevers. Q J Med (1956) 8.00
Isolation of the virus of herpes simplex and the demonstration of intranuclear inclusions in a case of acute encephalitis. Am J Pathol (1941) 6.38
Cytomegalovirus as a possible cause of a disease resembling infectious mononucleosis. Br Med J (1965) 6.04
Recovery of herpes-simplex virus from human trigeminal ganglions. N Engl J Med (1973) 5.66
Genetic relatedness of type 1 and type 2 herpes simplex viruses. J Virol (1972) 5.11
Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes. J Exp Med (1973) 5.03
Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med (1977) 5.02
Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus-producing cells. Nat New Biol (1972) 4.66
Recovery of herpes simplex virus from human sacral ganglions. N Engl J Med (1974) 4.49
Presence of EB virus nucleic acid homology in a "virus-free" line of Burkitt tumour cells. Nature (1970) 4.41
A serologic study of herpesvirus hominis strains by microneutralization tests. J Immunol (1967) 4.39
A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans. J Immunol (1970) 4.12
Herpesvirus hominis: isolation from human trigeminal ganglion. Science (1972) 3.97
Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst (1970) 3.94
Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature (1978) 3.73
Oncogenic transformation of hamster cells after exposure to herpes simplex virus type 2. Nat New Biol (1971) 3.73
Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero. Lancet (1974) 3.63
DISSEMINATED HERPES ZOSTER. A REPORT OF 17 CASES. Arch Intern Med (1964) 3.54
Fluorescent-antibody test for cytomegalovirus macroglobulin. N Engl J Med (1968) 3.51
The incidence of Herpesvirus hominis antibody in the population. J Hyg (Lond) (1967) 3.46
Malignant transformation of hamster embryo fibroblasts following exposure to ultraviolet-irradiated human cytomegalovirus. Virology (1973) 3.43
Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer (1976) 3.36
Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis. N Engl J Med (1973) 3.33
Structure and function of herpesvirus genomes. I. comparison of five HSV-1 and two HSV-2 strains by cleavage their DNA with eco R I restriction endonuclease. J Virol (1975) 3.32
Rise of cytomegalovirus antibodies in an infectious-mononucleosis-like syndrome after transfusion. Br Med J (1966) 3.32
Treatment of zoster with idoxuridine in dimethyl sulphoxide. Results of two double-blind controlled trials. Br Med J (1970) 3.30
Live vaccine used to prevent the spread of varicella in children in hospital. Lancet (1974) 3.24
Studies on shingles: is the virus ordinary chickenpox virus? Lancet (1954) 3.23
Type 1 and type 2 herpes simplex viruses: serological and biological differences. J Virol (1970) 3.21
Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus. Proc Natl Acad Sci U S A (1973) 3.14
An IgG-Fc receptor induced in cytomegalovirus-infected human fibroblasts. J Immunol (1976) 3.14
Pathogenesis of of cytomegalovirus infection. I. Activation of virus from bone marrow-derived lymphocytes by in vitro allogenic reaction. J Exp Med (1975) 3.13
Secondary fluorescent staining of virus antigens by rheumatoid factor and fluorescein-conjugated anti-IgM. Ann Rheum Dis (1973) 3.13
Seroepidemiologic studies of infectious mononucleosis with EB virus. N Engl J Med (1968) 3.12
The transplanted kidney as a source of cytomegalovirus infection. N Engl J Med (1975) 3.09
Epidemiology of cytomegalovirus infection after transplantation and immunosuppression. J Infect Dis (1975) 3.02
Varicella: report of two fatal cases with necropsy, virus isolation, and serologic studies. Am J Pathol (1957) 3.02
Efficacy of acycloguanosine (Wellcome 248U) against herpes-simplex corneal ulcers. Lancet (1979) 2.90
Zoster sine herpete. Br Med J (1958) 2.83
Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytes. Int J Cancer (1978) 2.81
EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nat New Biol (1973) 2.71
Latent cytomegalovirus infection in blood donors. Br Med J (1969) 2.61
Cytomegalovirus mononucleosis with jaundice as presenting sign. Lancet (1966) 2.59
Prevention of varicella by zoster immune globulin. N Engl J Med (1969) 2.57
Antibody reactions to virus-specific early antigens (EA) in patients with cytomegalovirus (CMV) infection. Clin Exp Immunol (1974) 2.57
X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet (1975) 2.57
Comparative studies of type 1 and type 2 & 'herpes simplex' viruses. Br J Exp Pathol (1968) 2.56
AN EPIDEMIOLOGIC APPROACH TO THE LYMPHOMAS OF AFRICAN CHILDREN AND BURKITT'S SACROMA OF THE JAWS. Perspect Biol Med (1964) 2.56
Isolation of latent herpes simplex virus from the superior cervical and vagus ganglions of human beings. N Engl J Med (1978) 2.55
The pulmonary lesions of chickenpox. Q J Med (1966) 2.50
Varicella encephalitis. Am J Med (1953) 2.49
THE INCIDENCE OF INFECTION WITH CYTOMEGALOVIRUS IN A NORMAL POPULATION. A SEROLOGICAL STUDY IN GREATER LONDON. J Hyg (Lond) (1965) 2.49
Prospective study of cytomegalovirus infection in pregnancy. Br Med J (1973) 2.48
School failure and deafness after "silent" congenital cytomegalovirus infection. N Engl J Med (1976) 2.46
Prevalence, incidence and persistence of EB virus antibody in young adults. N Engl J Med (1970) 2.45
Congenital cytomegalovirus infection: a fifteen year perspective. J Infect Dis (1971) 2.39
Congenital cytomegalovirus infection. N Engl J Med (1977) 2.35
Transfusion-acquired cytomegalovirus infection in newborn infants. Am J Dis Child (1974) 2.31
Isolation of cytomegalovirus and clinical manifestations of infection at different ages. Br Med J (1968) 2.29
Indirect hemagglutination test for detection of antibodies to Cytomegalovirus. Appl Microbiol (1971) 2.28
A study of herpes zoster particularly in its relationship to chickenpox. J Hyg (Lond) (1949) 2.19
Cytomegaloviremia following congenital infection. J Pediatr (1968) 2.13
Epstein-Barr virus-associated complement-fixing and nuclear antigens in Burkitt lymphoma biopsies. Int J Cancer (1974) 2.10
Herpesvirus infections of the human central nervous system. N Engl J Med (1967) 2.09
Cytomegalovirus infection after renal allotransplantation. JAMA (1967) 2.08
High-frequency establishment of human immunoglobulin-producing lymphoblastoid lines from normal and malignant lymphoid tissue and peripheral blood. Int J Cancer (1971) 2.06
Immunologic abnormalities induced by postperfusion cytomegalovirus infection. Ann Intern Med (1970) 2.06
Human leukocyte interferon for the treatment of herpes zoster in patients with cancer. N Engl J Med (1978) 2.04
Herpes-simplex-virus infection after renal transplantation. Lancet (1969) 2.03
Herpetic whitlow, a form of cross-infection in hospitals. Lancet (1959) 2.02
Complement-fixing antibodies against cytomegalovirus in different parts of the world. Bull World Health Organ (1973) 2.01
Acute necrotizing encephalitis: a problem in diagnosis. J Neurol Neurosurg Psychiatry (1967) 2.01
Fatal herpes simplex infection in a newborn infant. J Lab Clin Med (1951) 1.99
Comparative serial virologic and serologic studies of symptomatic and subclinical congenitally and natally acquired cytomegalovirus infections. J Infect Dis (1975) 1.97
Thymic origin of atypical lymphoid cells in infectious mononucleosis. Lancet (1973) 1.96
Acute hepatitis due to Herpes simplex virus in an adult. J Clin Pathol (1969) 1.93
Antibodies to Epstein-Barr virus-associated nuclear antigen in infectious mononucleosis. J Infect Dis (1974) 1.87
Hepato-Adrenal Necrosis with Intranuclear Inclusion Bodies: Report of a Case. Am J Pathol (1935) 1.86
CONTROLLED STUDIES OF IDU IN THE TREATMENT OF HERPETIC KERATITIS. Trans Ophthalmol Soc U K (1963) 1.86
The polypeptide and the DNA restriction enzyme profiles of spontaneous isolates of herpes simplex virus type 1 from explants of human trigeminal, superior cervical and vagus ganglia. J Gen Virol (1979) 1.86
Selective transformation of B lymphocytes by E.B. virus. Lancet (1973) 1.84
Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83
EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients. Int J Cancer (1976) 1.81
Cytomegalovirus pneumonia after human marrow transplantation. Ann Intern Med (1975) 1.80
Respiratory manifestations of chicken pox; special consideration of the features of primary varicella pneumonia. AMA Arch Intern Med (1956) 1.75
Clinically evident, non-terminal infections with herpesviruses and the wart virus in immunosuppressed renal allograft recipients. Br Med J (1970) 1.74
Epstein-Barr virus-specific IgM in infectious mononucleosis, Burkitt lymphoma, nasopharyngeal carcinoma. Lancet (1972) 1.73
Fatal infectious mononucleosis in a family. N Engl J Med (1974) 1.73
Improved glycine-extracted complement-fixing antigen for human cytomegalovirus. J Clin Microbiol (1977) 1.73
Varicella and cortisone. Pediatrics (1956) 1.73
Varicella-Zoster infection in patients with cancer. Ann Intern Med (1972) 1.73
Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis. Lancet (1972) 1.71
Herpesvirus hominis infection in patients with myeloproliferative and lymphoproliferative disorders. Br Med J (1972) 1.68
Clinical trials of immunization with the Towne 125 strain of human cytomegalovirus. J Infect Dis (1976) 1.68
Severe generalized primary herpes treated with cytarabine. Br Med J (1970) 1.67
Anti-complement immunofluorescence test for antibodies to human cytomegalovirus. J Clin Microbiol (1977) 1.66
Spontaneous cytomegalovirus mononucleosis. Clinical and laboratory observations in nine cases. Ann Intern Med (1973) 1.65
The activation of varicella-zoster virus infections by immunosuppressive therapy. J Lab Clin Med (1966) 1.65
Physical mapping of herpes simplex virus-induced polypeptides. J Virol (1978) 6.08
Recombinants between herpes simplex virus types 1 and 2: analyses of genome structures and expression of immediate early polypeptides. J Virol (1978) 4.87
Collaborative complementation study of temperature-sensitive mutants of herpes simplex virus types 1 and 2. J Virol (1978) 4.31
Temperature-sensitive mutants of herpes simplex virus type 2. J Gen Virol (1971) 3.04
The osmotic behaviour of Sephadex and its effects on chromatography. Biochem J (1968) 2.66
Rifampicin inhibits the growth of some mammalian viruses. Nature (1969) 2.65
Genetic and biochemical studies with herpesvirus. Cold Spring Harb Symp Quant Biol (1975) 2.47
Physical mapping of paar mutations of herpes simplex virus type 1 and type 2 by intertypic marker rescue. J Virol (1979) 2.41
HTLV-III antibody in Edinburgh drug addicts. Lancet (1985) 2.03
Outbreak of Legionnaires' disease in Glasgow Royal Infirmary: microbiological aspects. J Hyg (Lond) (1986) 1.99
Viral infection and renal transplant rejection. Br Med J (1972) 1.87
Temperature-sensitive mutants of herpes simplex virus type 2: description of three new complementation groups and studies on the inhibition of host cell DNA synthesis. J Gen Virol (1976) 1.86
Genetic interactions between temperature-sensitive mutants of types 1 and 2 herpes simplex viruses. J Gen Virol (1973) 1.78
Glasgow medical women 1951-4: their contribution and attitude to medical work. Br Med J (1969) 1.58
An approach to the study of phase separation in ternary aqueous systems. Biochem J (1968) 1.57
Herpesvirus proteins: DNA polymerase and pyrimidine deoxynucleoside kinase activities in temperature-sensitive mutants of herpes simplex virus type 2. J Gen Virol (1976) 1.39
Influenza types and patient population. Lancet (1995) 1.37
Distribution and transferability of plasmids in trimethoprim resistant urinary Escherichia coli. J Med Microbiol (1983) 1.35
Recombination in herpes simplex virus: mapping of mutations and analysis of intertypic recombinants. Cold Spring Harb Symp Quant Biol (1979) 1.34
Characterisation of temperature-sensitive mutants of herpes simplex virus type 2. Growth and DNA synthesis. Virology (1973) 1.33
Distribution and transferability of plasmids in trimethoprim-resistant urinary strains of Escherichia coli: a comparative study of hospital isolates. J Med Microbiol (1984) 1.29
Rubella screening and immunisation of schoolgirls: results six to seven years after vaccination. Br Med J (Clin Res Ed) (1982) 1.28
Comparison of five different methods of rubella IgM antibody testing. J Clin Pathol (1985) 1.21
Differential Mantoux testing in the diagnosis of atypical mycobacterial infection in children. Lancet (1966) 1.18
Alkaline DNase activity in cells infected with a temperature-sensitive mutant of herpes simplex virus type 2. J Virol (1978) 1.17
Temperature-sensitive mutants of herpes simplex virus type 2: a provisional linkage map based on recombination analysis. J Gen Virol (1976) 1.12
The fine structure of cells infected with temperature-sensitive mutants of herpes simplex virus type 2. J Gen Virol (1978) 1.12
Acyclovir. Br Med J (Clin Res Ed) (1982) 1.10
"Clean catch" urines in the newborn--bacteriology and cell excretion patterns in first week of life. Br Med J (1967) 1.08
Distribution and genetic location of Tn7 in trimethoprim-resistant Escherichia coli. J Med Microbiol (1986) 1.05
Human lymphoblastoid cell lines. I. Culture methods and examination for Epstein-Barr virus. J Natl Cancer Inst (1971) 1.05
The burden of chronic illness in local authority residential homes for the elderly. Health Trends (1991) 1.04
A prospective study of cytomegalovirus infection in pregnancy. I. Laboratory evidence of congenital infection following maternal primary and reactivated infection. J Infect (1981) 1.03
Rubella vaccination related to immunological status. Health Bull (Edinb) (1977) 1.00
A stable syncytial mutant of herpes simplex type 2 virus. J Gen Virol (1974) 1.00
The impact of a rubella prevention policy on the outcome of rubella in pregnancy. Br J Obstet Gynaecol (1986) 0.98
Rapid diagnosis of an outbreak of Legionnaires' disease at Glasgow Royal Infirmary. Thorax (1987) 0.95
Physical mapping of temperature-sensitive mutations of herpes simplex virus type 2 by marker rescue. J Gen Virol (1981) 0.93
Physical mapping of herpes simplex virus-coded functions and polypeptides by marker rescue and analysis of HSV-1/HSV-2 intertypic recombinants. IARC Sci Publ (1978) 0.90
Phase separation in an aqueous quaternary system. Biochem J (1970) 0.89
Abnormalities of circulating lymphocyte subsets in haemophiliacs in an AIDS-free population. Lancet (1984) 0.89
Collaborative study of temperature-sensitive mutants of herpes simplex virus type 2. J Virol (1976) 0.89
Rubella: immunity and vaccination in schoolgirls. Br Med J (Clin Res Ed) (1985) 0.88
Trimethoprim resistance in urinary coliforms from patients in the community: plasmids and R-transfer. J Antimicrob Chemother (1985) 0.87
Complementation of ts mutants by a herpes simplex virus ts-transformed cell line. Nature (1976) 0.87
Simultaneous infection of the meninges by Coxsackie B virus and Neisseria meningitidis in an elderly female. Lancet (1976) 0.87
Genetic retrieval of viral genome sequences from herpes simplex virus transformed cells. Nature (1980) 0.86
Detection of cytomegalovirus antigens in phagocytosed serum complexes from a patient with rheumatoid arthritis, vasculitis, peripheral neuropathy, cutaneous ulceration, and digital gangrene. Ann Rheum Dis (1992) 0.86
Restriction enzyme fingerprinting of trimethoprim resistance plasmids. Epidemiol Infect (1987) 0.85
Antimicrobial resistance and the ecology of Escherichia coli plasmids. J Hyg (Lond) (1984) 0.85
Do polyclonal rheumatoid factors carry an 'internal image' of cytomegalovirus, Epstein-Barr virus and nuclear antigens? Scand J Rheumatol Suppl (1988) 0.84
Garden fertilisers as a source of salmonellae. Lancet (1966) 0.83
Complementation with ts mutants of herpes simplex virus. J Gen Virol (1979) 0.82
How to do it. Use a library. Br Med J (1979) 0.81
Ocular vaccinia. Lancet (1974) 0.81
HLA antigens in adults negative for antibody to Epstein-Barr virus (EBV). Tissue Antigens (1981) 0.79
Congenital cytomegalovirus infection: a dilemma. Br Med J (Clin Res Ed) (1984) 0.78
Non-polio enteroviruses and motor neurone disease. J Clin Pathol (1988) 0.77
A comparison of the reactivity and immunogenicity of RA 27/3 strain rubella vaccine prepared in WI-38 or MRC5 human diploid cells. J Biol Stand (1986) 0.76
A comparison of the distribution of pneumococcal types in systemic disease and the upper respiratory tract in adults and children. Epidemiol Infect (1987) 0.75
False positive infectious mononucleosis serology in epilepsy. J Clin Pathol (1975) 0.75
Glasgow women medical students: some facts and figures. Br Med J (1971) 0.75
Avian tuberculosis. Scott Med J (1968) 0.75
The chief scientist reports...human cytomegalovirus. Health Bull (Edinb) (1980) 0.75
Conflicting information from British National Formulary and Data Sheet Compendium. Lancet (1984) 0.75
Some recent developments in virology. Scott Med J (1969) 0.75
Letter: Rapid diagnosis of virus infections. Lancet (1975) 0.75
A favourite score. Br Med J (1979) 0.75
A survey of cancer morbidity and mortality in vaccinees seven to 12 years after the administration of live vaccine propagated in human diploid cells. J Biol Stand (1983) 0.75
The growth of echovirus 1 in HEp-2 cells treated with antibody to the host cells. J Gen Virol (1969) 0.75
Neovitamin B 12 identified. Nature (1971) 0.75
The inhibition of group-T coliphages in Escherichia coli strain B by antibacterial serum. J Pathol Bacteriol (1966) 0.75
Influenza. Scott Med J (1978) 0.75
The screening of atherosclerotic patients: a new epidemiological approach. Atherosclerosis (1971) 0.75
Genetic and physiological studies with herpes simplex virus type 2 temperature-sensitive mutants. IARC Sci Publ (1975) 0.75
Raised urinary fibrin-degradation products, complement, and IgG during an influenza-like illness. Lancet (1977) 0.75
[Study of the action of basic aluminium clofibrate on blood lipids and hemostasis]. Therapeutique (1970) 0.75
The inhibitory effect of antibody to host cells on echovirus plaques in HEp-2 cells. J Gen Virol (1969) 0.75
Rubella epidemic: Scotland 1978. Comments on the rubella immunisation programmes. Health Bull (Edinb) (1980) 0.75
[Fibrinolytic action of aluminum bis-alpha-para-chlorophenoxy isobutyrate]. Therapie (1971) 0.75
Trimethoprim resistance. Lancet (1986) 0.75
[Fibrinolysis: kinetics of the lysis of a fibrin clot]. Rev Eur Etud Clin Biol (1970) 0.75
An epidemiological study: processing by a low-capacity computer. Comput Biomed Res (1971) 0.75
Antiviral therapy. Practitioner (1983) 0.75